Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01446913 · ClinicalTrials.gov registry record · NA
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
A NA study of Stroke and Transient Ischemic Attack, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 255
- Enrollment target
- 2
- Study locations
NCT01446913 is a NA study of Stroke and Transient Ischemic Attack that has completed, run by Yale University. The registered enrollment target is 255 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01446913, a NA study of Stroke and Transient Ischemic Attack, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 255 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to develop a novel study design to safely and ethically conduct a long-term randomized controlled trial among patients at high risk for both sleep apnea and cardiovascular events that will examine whether effective positive airway pressure(PAP) therapy reduces cardiovascular risk. Patients with transient ischemic attack(TIA) or stroke have a high prevalence of sleep apnea(60-80%), and they are at high risk of cardiovascular events(myocardial infarction, congestive heart failure, recurrent stroke, and cardiovascular death)in the first year post event, despite current prevent strategies. Therefore, the treatment of sleep apnea may represent a novel therapeutic target to reduce cardiovascular outcomes in this high risk population.
Conditions Studied
Interventions
- DEVICE Standard CPAP Intervention
- BEHAVIORAL Enhanced CPAP Intervention
Study Locations (2)
Connecticut
- Yale University - New Haven
Indiana
- University of Indiana - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01446913
The ClinicalTrials.gov registry entry for NCT01446913 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Standard CPAP Intervention is the first listed.
NCT01446913 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Indiana.
Frequently Asked Questions
What is clinical trial NCT01446913 about?
NCT01446913 is a clinical study titled "Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure". The goal of this study is to develop a novel study design to safely and ethically conduct a long-term randomized controlled trial among patients at high risk for both sleep apnea and cardiovascular events that will examine whether effective positive airway pressure(PAP) therapy reduces cardiovascula...
What is the current status of trial NCT01446913?
This trial is currently completed. It is a NA study. The enrollment target is 255 participants. The study started on 2011-05. Estimated completion is 2014-04.
What conditions does trial NCT01446913 study?
This clinical trial studies the following conditions: Stroke, Transient Ischemic Attack.
What interventions are being tested in trial NCT01446913?
The interventions under investigation include: Standard CPAP Intervention (DEVICE), Enhanced CPAP Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01446913?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01446913 being conducted?
This trial has 2 study locations across Connecticut, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.